It certainly is part of life. It's part of the dialogue between the generic industry and the innovator industry. Generally, there are resolutions that are reached over time.
It's quite clear that the generic industry brings tremendous value to the health care system. They help long-term affordability. Our focus is really on the innovations. For example, in the past 20 years, 40% of the increase of Canadians' life expectancy has been based on innovative medicines. In—